Algorithm to Identify PrEP Use for HIV Prevention
Author Information
Author(s): Mavragani Amaryllis, Wang Weijie, Gonzalez Charles J, Zucker Jason, Sullivan Patrick Sean DVM, PhD, Mera-Giler Robertino M MD, PhD, Bush Staci PA, Shvachko Valentina MS, Sarkodie Eleanor MPH, O'Farrell Daniel MSPH, Dubose Stephanie MPH, Magnuson David PhD
Primary Institution: Rollins School of Public Health Emory University
Hypothesis
Can an algorithm accurately distinguish TDF/FTC prescriptions for pre-exposure prophylaxis (PrEP) from other clinical indications?
Conclusion
The PrEP algorithm accurately classified most patients treated with TDF/FTC for HIV prevention.
Supporting Evidence
- The algorithm demonstrated high sensitivity (99.6%) and moderate specificity (49.6%) in electronic medical records.
- In a community health clinic, the algorithm showed high sensitivity (99.6%) and specificity (87%).
- The algorithm misclassified 4.6% of TDF/FTC exposure periods as PrEP when they were truly for chronic hepatitis B.
- 9.3% of TDF/FTC periods classified as PrEP were actually for postexposure prophylaxis.
Takeaway
Researchers created a computer program to help doctors figure out if patients are taking a medicine to prevent HIV or for other reasons.
Methodology
The study developed and validated an algorithm using prescription, diagnosis, and medical procedure data to identify TDF/FTC prescriptions for PrEP.
Potential Biases
Misclassification could occur due to incomplete or inaccurate medical records.
Limitations
The algorithm's specificity was variable, leading to potential misclassification of non-PrEP users as PrEP users.
Participant Demographics
Patients prescribed TDF/FTC for various indications, including HIV treatment and PrEP.
Statistical Information
P-Value
0.0001
Confidence Interval
95% CI 98.7%-100%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website